Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Victoria

$25,000.00

Structural comparison of human, murine, and rabbit antibodies

FY 2016-17

Summary
One of the roadblocks to evaluating the effectiveness of monoclonal antibody (mAb) therapy arises because most mAbs are generated using non-human hosts, which leads to rejection of the therapeutic as 'non-self'. The core service of our industrial collaborator, ImmunoPrecise (IPA), is to use mouse and rabbit systems to generate mAbs with the desired specificities and affinities; however, most non-human antibodies make poor human therapeutics due to a strong immune response against the mouse or rabbit antibody 'framework' and the formation of anti-drug antibodies (ADA).To minimize the generation of ADA, the key to antibody humanization is to understand how segments of polypeptide exposed to immune surveillance (i.e. on the antibody's surfaceand not directly involved in antigen binding) react with the immune system, and how they might be replaced with a corresponding human sequence while maintaining or increasing antigen specificity and affinity. To do this we propose to determine the crystal structure of the antibody combining site (if possible in the presence of antigen) using single crystal X-ray diffraction methods. For this project IPA has generated two rabbit mAbs and two mouse mAbs that recognizethe same antigen that will be used in crystallographic studies in Dr. Evans' lab in order to define their antigen-antibody interactions. Dr. Evans has extensive experience in determining the structures of murine antibody fragments (both Fab and Fv) unliganded and in the presence of antigen, with over 30 complexed mouse mAb structures, and the only rabbit Fv structure in the current literature.Within 2-4 years, IPA would like to offer customized mAb humanization packages that would range in price and scale from approximately $20,000 to $50,000 per mAb with the capacity to perform an estimated 4-8 projects per year. This represents an estimated value of between $80,000 to $400,000 per year to IPA and the Canadian economy, as well as increase the number of full-time jobs at IPA.
Program
Engage Grants Program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
499037-2016
Name nom
Evans, Stephen
Department département
Biochemistry and Microbiology
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Partie
1
Nb partie
1
Application title
Structural comparison of human, murine, and rabbit antibodies
Keyword
NSERC
Application summary
One of the roadblocks to evaluating the effectiveness of monoclonal antibody (mAb) therapy arises because most mAbs are generated using non-human hosts, which leads to rejection of the therapeutic as 'non-self'. The core service of our industrial collaborator, ImmunoPrecise (IPA), is to use mouse and rabbit systems to generate mAbs with the desired specificities and affinities; however, most non-human antibodies make poor human therapeutics due to a strong immune response against the mouse or rabbit antibody 'framework' and the formation of anti-drug antibodies (ADA).To minimize the generation of ADA, the key to antibody humanization is to understand how segments of polypeptide exposed to immune surveillance (i.e. on the antibody's surfaceand not directly involved in antigen binding) react with the immune system, and how they might be replaced with a corresponding human sequence while maintaining or increasing antigen specificity and affinity. To do this we propose to determine the crystal structure of the antibody combining site (if possible in the presence of antigen) using single crystal X-ray diffraction methods. For this project IPA has generated two rabbit mAbs and two mouse mAbs that recognizethe same antigen that will be used in crystallographic studies in Dr. Evans' lab in order to define their antigen-antibody interactions. Dr. Evans has extensive experience in determining the structures of murine antibody fragments (both Fab and Fv) unliganded and in the presence of antigen, with over 30 complexed mouse mAb structures, and the only rabbit Fv structure in the current literature.Within 2-4 years, IPA would like to offer customized mAb humanization packages that would range in price and scale from approximately $20,000 to $50,000 per mAb with the capacity to perform an estimated 4-8 projects per year. This represents an estimated value of between $80,000 to $400,000 per year to IPA and the Canadian economy, as well as increase the number of full-time jobs at IPA.